Brucellosis live vaccine (Rev.1 strain) is mainly used to prevent brucellosis in sheep, especially for sheep vaccination. The vaccine is administered by eye drops and has an immunity period of up to 36 months.

Applicable scenarios

‌    Sheep immunization‌: Rev.1 vaccine is mainly used for immunization of sheep, which can effectively prevent sheep brucellosis and protect sheep from Brucella infection‌.

    ‌Long-term protection‌: The vaccine provides up to 36 months of immune protection and is suitable for long-term protection of sheep from the threat of brucellosis‌.

Vaccination method and immune effect

    Vaccination method: Rev.1 vaccine is administered by eye drops, which is easy to operate and suitable for large-scale immunization.

    Immune effect: The vaccine can induce cellular and humoral immune responses in the host, provide good protection, and effectively prevent sheep brucellosis.

Background information and related data

    ‌Research and development background‌: Rev.1 vaccine is a new live vaccine independently developed by Jinyu Baoling Biological Pharmaceutical Co., Ltd. based on the standard strain of the World Organization for Animal Health (OIE), and obtained the new veterinary drug certificate and production license in September 2023‌.

    ‌Immunity period‌: The vaccine has an immunity period of 36 months, which is suitable for long-term protection of sheep flocks‌.